INVIVOSCRIBE INC.

In News

Invivoscribe Announces the PrepQuant™ System, an Integrated Sample Preparation Platform that Standardizes and Streamlines Pre-Analytical Workflows - Yahoo Finance

Yahoo Finance - Apr 14, 2026

Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification - Business Wire

Business Wire - Mar 26, 2026

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide - Business Wire

Business Wire - Feb 05, 2026

Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine - PR Newswire

PR Newswire - May 09, 2022

Genection: New Personalized Molecular Medicine Company - Clinical Lab Products

Clinical Lab Products - Sep 29, 2020

Kronos Bio and Invivoscribe Partner on Companion Diagnostic for Use with Entospletinib, Kronos Bio's Investigational Compound Being Developed for Patients with AML - PR Newswire

PR Newswire - Aug 16, 2022

Invivoscribe Releases the LymphoTrack Dx TRB Assay as CE-Marked IVD Kit, Completing the NGS Clonality Suite for the MiSeq Platform - NTB Kommunikasjon

NTB Kommunikasjon - May 15, 2018

Invivoscribe® Releases LeukoStrat® CDx FLT3 Mutation Assay as CE-marked IVD Assay Kit - Koreabizwire

Koreabizwire - Aug 01, 2017

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment